Convergent Multi‐Omics and Spatial Transcriptomics Identify MCL1 as a Clinically Actionable Mitochondrial Apoptosis Biomarker in Non‐Small Cell Lung Cancer
Mitochondrial apoptosis is a key regulator of tumor progression, therapeutic resistance, and immune evasion in non‐small cell lung cancer (NSCLC), yet promising candidate biomarkers remain inadequately defined. Using an integrative multi‐omics systems biology framework, we identified 16 mitochondrial apoptosis‐associat...